EGFR and glioblastoma: Epitinib is a selective EGFR-inhibitor that proved to be safe and promising in treating GBM and NSCLC with brain metastasis.788 Tesevatinib has been studied in both GBM and NSCLC with brain metastasis showing a good permeability through the blood-brain barrier.